£110m Recommended Cash Offer – Immunodiagnostic Systems Holdings

Peel Hunt is acting as sole Financial Adviser, R3 adviser, NOMAD and Corporate Broker to Immunodiagnostic Systems Holdings plc on its £110m Recommended Cash Offer from PerkinElmer (UK) Holdings Ltd (a wholly-owned subsidiary of PerkinElmer Inc., by way of a scheme of arrangement under Part 26 of the Companies Act 2006, as announced on 17th May, 2021.